Tradestie Institutional Equity Comparison Engine

RGNX vs BOLD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BOLD Overall Edge

BOLD Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boundless Bio, Inc. Common Stock (BOLD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while RGNX counters with relative strength in Valuation. Fundamentally, RGNX trades at N/M Forward P/E with -120.4% operating margin (-69.2% YoY revenue) versus BOLD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RGNX sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner RGNX
RGNX N/M vs BOLD N/M Fwd P/E
Growth & Margin Winner BOLD
Op Margin -120.4% vs 0.0% ยท YoY -69.2% vs +0.0%
Momentum & Technical Winner BOLD
1Y -34.5% vs +101.7% ยท 52W Pos 16% vs 62%
Options & Structure Winner BOLD
BREAKDOWN (53rd %ile IV) vs UNCLASSIFIED (N/A IV)
RGNX NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.16
-0.28% 1D
Market Cap $474.8M
1M Return -0.14%
1Y Return -34.49%
Forward P/E N/M
Unified AI Score
39.4 / 100 SELL
Tech 25.0 Fund 46.0 Flow 69.0 Mom 50.0
BOLD NASDAQ
Boundless Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.32
-2.52% 1D
Market Cap $56.2M
1M Return -4.92%
1Y Return +101.74%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 25.0 Fund 50.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RGNX -34.49% BOLD +101.74% Spread: +136.23 pp (BOLD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RGNX TTM Op. Margin: -120.4% BOLD TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RGNX vs BOLD. Trailing 12-month operating profitability (RGNX -120.4% vs BOLD 0.0%) and valuation multiples (RGNX N/M vs BOLD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RGNX (2) vs BOLD (6)
Institutional Metric RGNX BOLD Criterion Row Winner
Market Capitalization Scale $474.8M $56.2M Larger Scale RGNX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -69.2% +0.0% Higher Growth BOLD
Operating Margin (TTM) Profitability -120.4% 0.0% Higher Margin BOLD
Net Profit Margin Profitability -113.9% 0.0% Higher Margin BOLD
Return on Equity (ROE) Capital Efficiency -113.2% -64.6% Higher ROE BOLD
52-Week Range Position Momentum 16% ($5โ€“$16) 62% ($1โ€“$3) Stronger Trend BOLD
Beta / 30D Volatility Risk Regime 1.65ฮฒ ยท 74% Vol -0.08ฮฒ ยท 28% Vol Lower Realized Risk BOLD
Unified Institutional Score Composite Signal 39.4 / 100 (SELL) 36.8 / 100 (SELL) Higher Composite RGNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RGNX vs BOLD Buy Guide
RGNX BREAKDOWN
95d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RGNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BOLD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BOLD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RGNX nor BOLD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.